These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 18772050)

  • 1. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the serotonin system in ADHD: treatment implications.
    Oades RD
    Expert Rev Neurother; 2007 Oct; 7(10):1357-74. PubMed ID: 17939772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.
    Oades RD; Sadile AG; Sagvolden T; Viggiano D; Zuddas A; Devoto P; Aase H; Johansen EB; Ruocco LA; Russell VA
    Dev Sci; 2005 Mar; 8(2):122-31. PubMed ID: 15720370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging genetics in ADHD: a focus on cognitive control.
    Durston S; de Zeeuw P; Staal WG
    Neurosci Biobehav Rev; 2009 May; 33(5):674-89. PubMed ID: 18789356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder.
    Hercigonja Novkovic V; Rudan V; Pivac N; Nedic G; Muck-Seler D
    Neuropsychobiology; 2009; 59(1):17-22. PubMed ID: 19221444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin/dopamine interaction in learning.
    Olvera-Cortés ME; Anguiano-Rodríguez P; López-Vázquez MA; Alfaro JM
    Prog Brain Res; 2008; 172():567-602. PubMed ID: 18772051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder.
    Quist JF; Barr CL; Schachar R; Roberts W; Malone M; Tannock R; Basile VS; Beitchman J; Kennedy JL
    Mol Psychiatry; 2003 Jan; 8(1):98-102. PubMed ID: 12556913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
    Pliszka SR
    Biol Psychiatry; 2005 Jun; 57(11):1385-90. PubMed ID: 15950012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic background of ADHD: population studies, genes of the catecholamine system].
    Słopién A; Dmitrzak-Weglarz M; Rybakowski F; Rajewski A; Hauser J
    Psychiatr Pol; 2006; 40(1):19-31. PubMed ID: 16756025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converging methods in studying attention-deficit/hyperactivity disorder: what can we learn from neuroimaging and genetics?
    Durston S
    Dev Psychopathol; 2008; 20(4):1133-43. PubMed ID: 18838034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.